207 related articles for article (PubMed ID: 27351281)
1. Obesity does not promote tumorigenesis of localized patient-derived prostate cancer xenografts.
Lo JC; Clark AK; Ascui N; Frydenberg M; Risbridger GP; Taylor RA; Watt MJ
Oncotarget; 2016 Jul; 7(30):47650-47662. PubMed ID: 27351281
[TBL] [Abstract][Full Text] [Related]
2. Periprostatic adipose tissue (PPAT) supernatant from obese mice releases anticontractile substances and increases human prostate epithelial cell proliferation: the role of nitric oxide and adenosine.
Passos GR; de Oliveira MG; Ghezzi AC; Mello GC; Levi D'Ancona CA; Teixeira SA; Muscará MN; Grespan Bottoli CB; Vilela de Melo L; de Oliveira E; Antunes E; Mónica FZ
Front Pharmacol; 2023; 14():1145860. PubMed ID: 37492091
[No Abstract] [Full Text] [Related]
3. Periprostatic Adipose Tissue Favors Prostate Cancer Cell Invasion in an Obesity-Dependent Manner: Role of Oxidative Stress.
Laurent V; Toulet A; Attané C; Milhas D; Dauvillier S; Zaidi F; Clement E; Cinato M; Le Gonidec S; Guérard A; Lehuédé C; Garandeau D; Nieto L; Renaud-Gabardos E; Prats AC; Valet P; Malavaud B; Muller C
Mol Cancer Res; 2019 Mar; 17(3):821-835. PubMed ID: 30606769
[TBL] [Abstract][Full Text] [Related]
4. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
[TBL] [Abstract][Full Text] [Related]
5. Peri-prostatic adipose tissue: the metabolic microenvironment of prostate cancer.
Nassar ZD; Aref AT; Miladinovic D; Mah CY; Raj GV; Hoy AJ; Butler LM
BJU Int; 2018 May; 121 Suppl 3():9-21. PubMed ID: 29460324
[TBL] [Abstract][Full Text] [Related]
6. Establishment of primary patient-derived xenografts of palliative TURP specimens to study castrate-resistant prostate cancer.
Lawrence MG; Pook DW; Wang H; Porter LH; Frydenberg M; Kourambas J; Appu S; Poole C; Beardsley EK; Ryan A; Norden S; Papargiris MM; Risbridger GP; Taylor RA
Prostate; 2015 Sep; 75(13):1475-83. PubMed ID: 26177841
[TBL] [Abstract][Full Text] [Related]
7. Influence of the periprostatic adipose tissue in obesity-associated mouse urethral dysfunction and oxidative stress: Effect of resveratrol treatment.
Alexandre EC; Calmasini FB; Sponton ACDS; de Oliveira MG; André DM; Silva FH; Delbin MA; Mónica FZ; Antunes E
Eur J Pharmacol; 2018 Oct; 836():25-33. PubMed ID: 30102890
[TBL] [Abstract][Full Text] [Related]
8. Adipose stromal cell targeting suppresses prostate cancer epithelial-mesenchymal transition and chemoresistance.
Su F; Ahn S; Saha A; DiGiovanni J; Kolonin MG
Oncogene; 2019 Mar; 38(11):1979-1988. PubMed ID: 30361686
[TBL] [Abstract][Full Text] [Related]
9. Periprostatic adipose tissue from obese prostate cancer patients promotes tumor and endothelial cell proliferation: a functional and MR imaging pilot study.
Venkatasubramanian PN; Brendler CB; Plunkett BA; Crawford SE; Fitchev PS; Morgan G; Cornwell ML; McGuire MS; Wyrwicz AM; Doll JA
Prostate; 2014 Feb; 74(3):326-35. PubMed ID: 24571013
[TBL] [Abstract][Full Text] [Related]
10. Changes in periprostatic adipose tissue induced by 5α-reductase inhibitors.
Taussky D; Barkati M; Campeau S; Zerouali K; Nadiri A; Saad F; Delouya G
Andrology; 2017 May; 5(3):511-515. PubMed ID: 28296186
[TBL] [Abstract][Full Text] [Related]
11. Human periprostatic adipose tissue: its influence on prostate cancer cells.
Sacca PA; Creydt VP; Choi H; Mazza ON; Fletcher SJ; Vallone VB; Scorticati C; Chasseing NA; Calvo JC
Cell Physiol Biochem; 2012; 30(1):113-22. PubMed ID: 22759960
[TBL] [Abstract][Full Text] [Related]
12. Obesity and prostate cancer: gene expression signature of human periprostatic adipose tissue.
Ribeiro R; Monteiro C; Catalán V; Hu P; Cunha V; Rodríguez A; Gómez-Ambrosi J; Fraga A; Príncipe P; Lobato C; Lobo F; Morais A; Silva V; Sanches-Magalhães J; Oliveira J; Pina F; Lopes C; Medeiros R; Frühbeck G
BMC Med; 2012 Sep; 10():108. PubMed ID: 23009291
[TBL] [Abstract][Full Text] [Related]
13. Variable effects of periprostatic adipose tissue on prostate cancer cells: Role of adipose tissue lipid composition and cancer cells related factors.
Cancel M; Crottes D; Bellanger D; Bruyère F; Mousset C; Pinault M; Mahéo K; Fromont G
Prostate; 2024 Mar; 84(4):358-367. PubMed ID: 38112233
[TBL] [Abstract][Full Text] [Related]
14. The relationship between obesity and prostate cancer: from genetics to disease treatment and prevention.
Lughezzani G
BMC Med; 2012 Sep; 10():109. PubMed ID: 23009325
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Periprostatic and Subcutaneous Adipose Tissue Lipolysis and Adipocyte Size from Men with Localized Prostate Cancer.
Miladinovic D; Cusick T; Mahon KL; Haynes AM; Cortie CH; Meyer BJ; Stricker PD; Wittert GA; Butler LM; Horvath LG; Hoy AJ
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32481537
[TBL] [Abstract][Full Text] [Related]
16. Hyperinsulinemia enhances interleukin-17-induced inflammation to promote prostate cancer development in obese mice through inhibiting glycogen synthase kinase 3-mediated phosphorylation and degradation of interleukin-17 receptor.
Liu S; Zhang Q; Chen C; Ge D; Qu Y; Chen R; Fan YM; Li N; Tang WW; Zhang W; Zhang K; Wang AR; Rowan BG; Hill SM; Sartor O; Abdel-Mageed AB; Myers L; Lin Q; You Z
Oncotarget; 2016 Mar; 7(12):13651-66. PubMed ID: 26871944
[TBL] [Abstract][Full Text] [Related]
17. Establishing a cryopreservation protocol for patient-derived xenografts of prostate cancer.
Porter LH; Lawrence MG; Wang H; Clark AK; Bakshi A; Obinata D; Goode D; Papargiris M; Mural ; Clouston D; Ryan A; Norden S; Corey E; Nelson PS; Isaacs JT; Grummet J; Kourambas J; Sandhu S; Murphy DG; Pook D; Frydenberg M; Taylor RA; Risbridger GP
Prostate; 2019 Aug; 79(11):1326-1337. PubMed ID: 31212368
[TBL] [Abstract][Full Text] [Related]
18. Lipophagy and prostate cancer: association with disease aggressiveness and proximity to periprostatic adipose tissue.
Fontaine A; Bellanger D; Guibon R; Bruyère F; Brisson L; Fromont G
J Pathol; 2021 Oct; 255(2):166-176. PubMed ID: 34219239
[TBL] [Abstract][Full Text] [Related]
19. Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis.
Risbridger GP; Taylor RA; Clouston D; Sliwinski A; Thorne H; Hunter S; Li J; Mitchell G; Murphy D; Frydenberg M; Pook D; Pedersen J; Toivanen R; Wang H; Papargiris M; Lawrence MG; Bolton DM
Eur Urol; 2015 Mar; 67(3):496-503. PubMed ID: 25154392
[TBL] [Abstract][Full Text] [Related]
20. Periprostatic adipose tissue thromboinflammation triggers prostatic neoplasia in early metabolic impairment: Interruption by rivaroxaban.
AlZaim I; El-Nikhely N; Al-Saidi A; Mougharbil N; Darwiche N; Abou-Kheir W; El-Yazbi AF
Life Sci; 2023 Dec; 334():122225. PubMed ID: 38084675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
